NASDAQ:MNMD

Mind Medicine (MindMed) News Headlines

3.79
+0.06 (+1.61 %)
(As of 06/17/2021 04:44 PM ET)
Add
Compare
Today's Range
3.61
▼
3.83
50-Day Range N/A
52-Week Range
0.29
▼
5.77
Volume8.37 million shs
Average Volume6.59 million shs
Market Capitalization$1.16 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Mind Medicine (MindMed) (NASDAQ MNMD) News Headlines Today

SourceHeadline
Is Mind Medicine a Buy?Is Mind Medicine a Buy?
msn.com - June 17 at 8:02 AM
MindMed Appoints Pharmaceutical Veteran Peter Bergethon, M.D. to Scientific Advisory BoardMindMed Appoints Pharmaceutical Veteran Peter Bergethon, M.D. to Scientific Advisory Board
finance.yahoo.com - June 17 at 8:02 AM
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up to $3.62Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up to $3.62
americanbankingnews.com - June 16 at 11:40 AM
“The Science Behind Using Psychedelics To Treat Mental Health Disorders And Addiction Is Compelling”“The Science Behind Using Psychedelics To Treat Mental Health Disorders And Addiction Is Compelling”
finance.yahoo.com - June 16 at 9:14 AM
Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 4.6%Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 4.6%
americanbankingnews.com - June 14 at 12:40 PM
Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Up 7.7%Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Up 7.7%
americanbankingnews.com - June 11 at 11:38 AM
Mind Medicine: Incomplete Nasdaq Uplisting Application Fueled A 1,400% Rally At Which Insiders Began SellingMind Medicine: Incomplete Nasdaq Uplisting Application Fueled A 1,400% Rally At Which Insiders Began Selling
seekingalpha.com - June 9 at 11:43 PM
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Down to $3.71Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Down to $3.71
americanbankingnews.com - June 9 at 10:50 AM
Mind Medicine (MindMed) Inc. Subordinate Voting Shares (NASDAQ:MNMD) Stock Price Down 7.6%Mind Medicine (MindMed) Inc. Subordinate Voting Shares (NASDAQ:MNMD) Stock Price Down 7.6%
americanbankingnews.com - June 2 at 2:00 AM
NEO Exchange Announces Eligibility In MSCI IndexesNEO Exchange Announces Eligibility In MSCI Indexes
finance.yahoo.com - May 28 at 1:18 PM
MindMed announces shareholder Meeting ResultsMindMed announces shareholder Meeting Results
finance.yahoo.com - May 27 at 7:40 PM
MindMed and Liechti Lab in Basel Switzerland Publish First Pharmacogenetic Data on LSD to Help Guide Personalized DosingMindMed and Liechti Lab in Basel Switzerland Publish First Pharmacogenetic Data on LSD to Help Guide Personalized Dosing
finance.yahoo.com - May 26 at 7:54 AM
MindMed Announces Launch of Collaboration with Nextage Therapeutics Brain Targeting Liposome SystemMindMed Announces Launch of Collaboration with Nextage Therapeutics' Brain Targeting Liposome System
finance.yahoo.com - May 24 at 9:41 AM
The Chopra Foundation and MindMed Enter Into Letter of Intent to Partner on the Future of Psychedelic Medicines & Mental WellbeingThe Chopra Foundation and MindMed Enter Into Letter of Intent to Partner on the Future of Psychedelic Medicines & Mental Wellbeing
finance.yahoo.com - May 18 at 11:03 PM
MindMed Receives FDA Type C Meeting Response for Project Lucy Phase 2b Clinical TrialMindMed Receives FDA Type C Meeting Response for Project Lucy Phase 2b Clinical Trial
finance.yahoo.com - May 17 at 9:25 AM
MindMed Announces 2021 Q1 Financial Results; Cash Balance of $160m USD ($194m CAD) to Execute on Diverse Clinical PipelineMindMed Announces 2021 Q1 Financial Results; Cash Balance of $160m USD ($194m CAD) to Execute on Diverse Clinical Pipeline
finance.yahoo.com - May 14 at 8:17 AM
MindMed Announces Appointment of Dr. Sarah Y. Vinson as Additional DirectorMindMed Announces Appointment of Dr. Sarah Y. Vinson as Additional Director
finance.yahoo.com - May 14 at 8:17 AM
Psychedelics Stock MindMed Debuts On NasdaqPsychedelics Stock MindMed Debuts On Nasdaq
benzinga.com - April 27 at 4:43 PM
Mind Medicine (MindMed) Inc. Subordinate Voting Shares (MNMD)Mind Medicine (MindMed) Inc. Subordinate Voting Shares (MNMD)
nasdaq.com - April 27 at 4:43 PM
This page was last updated on 6/17/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.